Occlude Defect ,
To provide global doctors and patients with safe and innovate medical devices to treat cardiovascular diseases
Being an innovative company, we consistently explore new idea and methods
Las Vegas, United States – From September 5th to September 8th, Lifetech Scientific Corporation attended the 21st Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS)
the 7th Congress of Asia Pacific Pediatric Cardiac Society (APPCS 2018) took place in the island of Bali, Indonesia, and gathered more than 600 pediatric cardiology experts from more than 20 countries and districts around the world.
June 6, 2018 was the sixth China Atrial Fibrillation Day, which happily coincided with the first anniversary of launch of Lifetech's proprietary LAmbre left atrial appendage occluder
On April 25, 2018, Lifetech was included in the ranking of the "the Most Attentive List Company by Institution Investors of Shenzhen-Hongkong Stock Connect "
On April 19, 2018, Lifetech (1302.HK) was awarded as "listed company with the Best Medical Devies and Diagnosis "
LifeTech Scientific (Shenzhen) Co., Ltd. as the winner of the first prize of the Guangdong Science and Technology Award for 2017
Lifetech is a leading developer, manufacturer and vendor of advanced minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders.
Founded in 1999, we are now the second largest provider of congenital heart defect occluders in the world and the largest provider to BRIC countries.